JSP
LLY icon

Jackson Square Partners’s Eli Lilly LLY Stock Holding History

Jackson Square Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,704
Closed -$2.83M – 26
2025
Q3 		$2.83M Sell
3,704
-63
-2% -$46.9K 1.14% 31
2025
Q2 		$2.94M Sell
3,767
-560
-13% -$435K 1.09% 41
2025
Q1 		$3.57M Sell
4,327
-194
-4% -$161K 0.48% 50
2024
Q4 		$3.49M Sell
4,521
-231
-5% -$191K 0.36% 55
2024
Q3 		$4.21M Sell
4,752
-1,785
-27% -$1.6M 0.36% 57
2024
Q2 		$5.92M Sell
6,537
-781
-11% -$625K 0.36% 55
2024
Q1 		$5.69M Sell
7,318
-71
-1% -$50.5K 0.24% 61
2023
Q4 		$4.31M Buy
+7,389
New +$4.31M 0.14% 63

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jackson Square Partners's LLY Position: Q4 2025 in Review

Jackson Square Partners sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 3,704 shares — an estimated $2.83M sold.

Jackson Square Partners first reported a position in LLY in Q4 2023 and held it in 8 quarters. The position peaked at $5.92M in Q2 2024. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Jackson Square Partners reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Jackson Square Partners sold 3,704 Eli Lilly shares in Q4 2025, an estimated $2.83M.
  • Jackson Square Partners first reported a position in Eli Lilly in Q4 2023 and held it in 8 quarters.
  • Jackson Square Partners's Eli Lilly position peaked at $5.92M in Q2 2024.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Jackson Square Partners's 13F filing for Q4 2025.